Actinium Pharmaceuticals
ATNM
#9768
Rank
NZ$87.6 M
Marketcap
NZ$2.81
Share price
-2.07%
Change (1 day)
32.54%
Change (1 year)

Market capitalization of Actinium Pharmaceuticals (ATNM)

Market cap: NZ$87.6 Million

As of December 2025 Actinium Pharmaceuticals has a market cap of NZ$87.6 Million. This makes Actinium Pharmaceuticals the world's 9768th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Actinium Pharmaceuticals from 2011 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$87.6 M31.98%
2024NZ$66.37 M-69.86%
2023NZ$0.22 B-48.48%
2022NZ$0.42 B119.39%
2021NZ$0.19 B2.8%
2020NZ$0.18 B256.01%
2019NZ$53.23 M-20.25%
2018NZ$66.75 M-10.72%
2017NZ$74.77 M6.18%
2016NZ$70.41 M-66.14%
2015NZ$0.20 B-7.7%
2014NZ$0.22 B27.96%
2013NZ$0.17 B351.41%
2012NZ$39 M2380.93%
2011NZ$1.57 M

End of Day market cap according to different sources

On Dec 17th, 2025 the market cap of Actinium Pharmaceuticals was reported to be:

NZ$89.49 Million
by Nasdaq info icon info icon
NZ$89.76 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Genocea Biosciences
GNCA
NZ$0.01 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$17.29 B 19,637.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$5.73 B 6,444.22%๐Ÿ‡บ๐Ÿ‡ธ USA